![Mark Carlton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Mark Carlton
Società | Posizione | Inizio | Fine |
---|---|---|---|
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Direttore Tecnico/Scientifico/R&S | 01/01/2016 | - |
Fondatore | 01/01/2016 | - |
Storia della carriera di Mark Carlton
Precedenti posizioni note di Mark Carlton
Società | Posizione | Inizio | Fine |
---|---|---|---|
Paradigm Therapeutics Ltd.
![]() Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | Direttore/Membro del Consiglio | 01/01/1999 | 12/03/2007 |
Direttore Tecnico/Scientifico/R&S | 01/01/1999 | 12/03/2007 |
Formazione di Mark Carlton
University of Cambridge | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 3 |
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Paradigm Therapeutics Ltd.
![]() Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | Health Technology |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Mark Carlton
- Esperienza